Anvisa Approves Generic Liraglutide Pens by EMS for Weight and Diabetes

Brazil's health regulator Anvisa approved a generic version of liraglutide from EMS, marketed as Olire for weight control and Lirux for blood sugar management. This increases competition in the GLP-1 market, potentially lowering costs and improving access. The move follows global trends of patent expirations on weight-loss drugs.